Strong Association of De Novo Copy Number Mutations with Autism
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
We tested the hypothesis that de novo copy number variation (CNV) is associated with autism spectrum disorders (ASDs). We performed comparative genomic hybridization (CGH) on the genomic DNA of patients and unaffected subjects to detect copy number variants not present in their respective parents. Candidate genomic regions were validated by higher-resolution CGH, paternity testing, cytogenetics, fluorescence in situ hybridization, and microsatellite genotyping. Confirmed de novo CNVs were significantly associated with autism ( P = 0.0005). Such CNVs were identified in 12 out of 118 (10%) of patients with sporadic autism, in 2 out of 77 (3%) of patients with an affected first-degree relative, and in 2 out of 196 (1%) of controls. Most de novo CNVs were smaller than microscopic resolution. Affected genomic regions were highly heterogeneous and included mutations of single genes. These findings establish de novo germline mutation as a more significant risk factor for ASD than previously recognized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Accordingly, such CNVs must frequently occur as recurrent de novo mutations.”
From De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia (2012) · cites this paper as [23]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Collectively, these de novo heterozygous mutations are rare and confer relatively large risks of ASD 41 .”
From Autism spectrum disorder (2020) · cites this paper as [41]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CNVs and SNPs have both been reported to play a major role in autism incidence (36–41).”
From Gene × Environment Interactions in Autism Spectrum Disorders: Role of Epigenetic Mechanisms (2014) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In 45 ASD trios we detected and validated all 3 de novo CNVs that were identified in our previous study and in addition, we identified one novel de novo CNV 38 kb in size (Table S8).”
From High frequencies of de novo CNVs in bipolar disorder and schizophrenia (2011) · cites this paper as Sebat et al., 2007
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, a small set of autism spectrum disorder (ASD) trios (n = 45), all of which had been included in a previous study (Sebat et al., 2007) and three of which carried known de novo CNVs, were included as a “positive control” to confirm the sensitivity of our methods for detecting de novo events.”
From High frequencies of de novo CNVs in bipolar disorder and schizophrenia (2011) · cites this paper as Sebat et al., 2007
Experimental — accuracy not yet measured
25 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Human Genome Browser at UCSC
Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M., & Haussler, A. D. (2002) · Genome Research · doi:10.1101/gr.229102 · Cited by 10,400
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990
Oxytocin increases trust in humans
Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005) · Nature · doi:10.1038/nature03701 · Cited by 3,690
Detection of large-scale variation in the human genome
Iafrate, A. J., Feuk, L., Rivera, M. N., Listewnik, M. L., Donahoe, P. K., Qi, Y., Scherer, S. W., & Lee, C. (2004) · Nature Genetics · doi:10.1038/ng1416 · Cited by 2,892
Large-scale copy number polymorphism in the human genome
Sebat, J., Lakshmi, B., Troge, J., Alexander, J., Young, J., Lundin, P., Månér, S., Massa, H., Walker, M., Chi, M., et al. (2004) · Science · doi:10.1126/science.1098918 · Cited by 2,557
Self-citationStructural variation in the human genome
Feuk, L., Carson, A. R., & Scherer, S. W. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1767 · Cited by 2,034
Identification and characterization of the tuberous sclerosis gene on chromosome 16
(1993) · Cell · doi:10.1016/0092-8674(93)90618-z · Cited by 1,645
Durand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602
Are Rare Variants Responsible for Susceptibility to Complex Diseases?
Pritchard, J. K. (2001) · The American Journal of Human Genetics · doi:10.1086/321272 · Cited by 1,197
Social amnesia in mice lacking the oxytocin gene
Ferguson, J. N., Young, L. J., Hearn, E. F., Matzuk, M. M., Insel, T. R., & Winslow, J. T. (2000) · Nature Genetics · doi:10.1038/77040 · Cited by 1,130
Research works printed but not linked: 1
- Fombonne E. J Clin Psychiatry. 2005;66(suppl 10):3. [PubMed] [Google Scholar]
Cited by
Items 701–800 of 1,023
Autism-Associated Haplotype Affects the Regulation of the Homeobox Gene, ENGRAILED 2
Benayed, R., Choi, J., Matteson, P. G., Gharani, N., Kamdar, S., Brzustowicz, L. M., & Millonig, J. H. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.05.027 · Cited by 81
Copy Number Variation in Familial Parkinson Disease
Pankratz, N., Dumitriu, A., Hetrick, K. N., Sun, M., Latourelle, J. C., Wilk, J. B., Halter, C., Doheny, K. F., Gusella, J. F., Nichols, W. C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020988 · Cited by 81
“Copy number variants (CNVs), defined as structural changes in DNA consisting of deletions or duplications of segments larger than 1 kb compared to a reference genome [1], have been shown to be a disease producing mechanism in disorders such as Charcot–Marie–Tooth neuropathy, as well as a risk factor in some common, co…”
BackgroundA genetic model for neurodevelopmental disease
Coe, B. P., Girirajan, S., & Eichler, E. E. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.04.007 · Cited by 83
Genetic architecture of autism spectrum disorder: Lessons from large-scale genomic studies
Choi, L., & An, J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.028 · Cited by 87
“A landmark study conducted in 2007 examined CNVs and found a significant increase in de novo CNVs in ASD cases compared with the controls (Sebat et al., 2007).”
Expression of autism spectrum and schizophrenia in patients with a 22q11.2 deletion
Vorstman, J. A. S., Breetvelt, E., Thode, K. I., Chow, E. W. C., & Bassett, A. S. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.10.010 · Cited by 87
Hönekopp, J. (2012) · Autism Research · doi:10.1002/aur.1230 · Cited by 76
Pharmacogenomics: The Promise of Personalized Medicine for CNS Disorders
de León, J. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.147 · Cited by 87
“Autism (Sebat et al, 2007) and schizophrenia (Walsh et al, 2008) may be associated with CNVs; currently it is not known whether these described CNVs have relevance for treatment or not.”
BackgroundSchulze, T. G. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.10.005 · Cited by 91
Schizophrenia genetics: advancing on two fronts
Owen, M. J., Williams, H. J., & O’Donovan, M. C. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.02.008 · Cited by 100
“Amongst these, neurodevelopmental disorders including autism and mental retardation have been the most prominent focus of CNV research, and the first generation of genome-wide CNV scans have shown that de novo CNV mutations of about 100 kb or more contribute to about 10% of cases of these disorders [20,21].”
BackgroundThe introduction of arrays in prenatal diagnosis: A special challenge
Vetro, A., Bouman, K., Hastings, R. J., McMullan, D. J., Vermeesch, J. R., Miller, K., Sikkema‐Raddatz, B., Ledbetter, D. H., Zuffardi, O., & van Ravenswaaij‐Arts, C. M. A. (2012) · Human Mutation · doi:10.1002/humu.22050 · Cited by 88
Self-citationCappi, C., Hounie, A. G., Mariani, D. B., Diniz, J. B., Silva, A. R. T., Reis, V. N. S., Busso, A. F., Silva, A. G., Fidalgo, F., Rogatto, S. R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110198 · Cited by 77
“The main CNVs associated with psychiatric disorders have generally been rare variants in genes involved in synaptogenesis, neuronal and axonal mobility, protein degradation via the ubiquitin-proteasome system (ubiquitin signaling), protein complexes and postsynaptic signaling [11,12,38–48].”
BackgroundGenetic architecture of reciprocal CNVs
Golzio, C., & Katsanis, N. (2013) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.04.013 · Cited by 77
“Although some CNVs are found at high frequency in human populations and are thus thought to be a potential source of genetic diversity [2 ,3 ], larger CNVs, especially de novo, are associated frequently with human disorders [4]; in addition to the documented involvement of CNVs in birth defects (e.g. craniofacial, car…”
BackgroundInfluentialLINE‐1 retrotransposons in healthy and diseased human brain
Suarez, N. A., Macia, Á., & Muotri, A. R. (2017) · Developmental Neurobiology · doi:10.1002/dneu.22567 · Cited by 87
“Approximately 5 million years ago, after the Pan-Homo split, the primate brain size dramatically increased (Semendeferi et al., 2002) and in Homo, the subfamilies L1Hs, AluYa5, AluYb8, and SVA were the most active, and are still the most active in the human genome today (Cordaux et al., 2006; Xing…”
Identifying structural variants using linked-read sequencing data
Elyanow, R., Wu, H.-T., & Raphael, B. J. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx712 · Cited by 91
Insights into the Pathogenesis of Autism
Sutcliffe, J. S. (2008) · Science · doi:10.1126/science.1160555 · Cited by 76
Self-citationBölte, S. (2014) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.12495 · Cited by 71
CNV and nervous system diseases – what’s new?
Gu, W., & Lupski, J. R. (2008) · Cytogenetic and Genome Research · doi:10.1159/000184692 · Cited by 79
The Growing Importance of CNVs: New Insights for Detection and Clinical Interpretation
Valsesia, A., Macé, A., Jacquemont, S., Beckmann, J. S., & Kutalik, Z. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00092 · Cited by 90
Coughlin, C. R., Scharer, G. H., & Shaikh, T. H. (2012) · Genome Medicine · doi:10.1186/gm381 · Cited by 89
“CNVs that involve genomic fragments containing one or more dosage-sensitive genes can result in genetic disorders and complex diseases, including autism, cancer, immune defi ciency, and neuro degenerative and neuropsychiatric disorders [2-8].”
BackgroundFamily-Based Genome-Wide Association Studies
Benyamin, B., Visscher, P. M., & McRae, A. F. (2009) · Pharmacogenomics · doi:10.2217/14622416.10.2.181 · Cited by 78
Pérez‐Crespo, L., Prats‐Uribe, A., Tobias, A., Duran‐Tauleria, E., Coronado, R., Hervás, A., & Guxens, M. (2019) · Autism Research · doi:10.1002/aur.2172 · Cited by 57
“Some studies have demonstrated that girls could be protected from inherited and de novo genetic risk variants for ASD [Constantino, Zhang, Frazier, Abbacchi, & Law, 2010; Sebat et al., 2007].”
BackgroundStergiakouli (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s11322 · Cited by 78
“The presence of a CNV in an individual does not necessarily mean that there is a phenotypic effect, since CNVs are part of the normal variation of the human genome.(71) However, it has emerged that large, rare CNVs can increase risk of disorder, especially those of a neurodevelopmental nature such as autism(72) and me…”
Analysis of somatic mutations in 131 human brains reveals aging-associated hypermutability
Bae, T., Fasching, L., Wang, Y., Shin, J. H., Suvakov, M., Jang, Y., Norton, S., Dias, C., Mariani, J., Jourdon, A., et al. (2022) · Science · doi:10.1126/science.abm6222 · Cited by 72
Self-citationNeuroanatomical phenotypes in a mouse model of the 22q11.2 microdeletion
Ellegood, J., Markx, S., Lerch, J. P., Steadman, P. E., Genç, C., Provenzano, F., Kushner, S. A., Henkelman, R. M., Karayiorgou, M., & Gogos, J. A. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.112 · Cited by 72
Butler, M. G., Rafi, S. K., & Manzardo, A. M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16036464 · Cited by 89
“In multiplex families having two or more affected children with autism, the recurrence risk may be as high as 25%, but generally ranges from 13% [29] to 19% [30] if due to single-gene disturbances as the cause, a major focus of this illustrative review.”
BackgroundYin, J., & Schaaf, C. P. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4942 · Cited by 81
“Notably, incomplete penetrance and variable expressivity of phenotypes are frequently seen, even within the same family.(44,45,47)”
BackgroundCarter, M., Nikkel, S., Fernandez, B., Marshall, C., Noor, A., Lionel, A., Prasad, A., Pinto, D., Joseph-George, A., Noakes, C., et al. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01578.x · Cited by 77
Gazzellone, M. J., Zarrei, M., Burton, C. L., Walker, S., Uddin, M., Shaheen, S. M., Coste, J., Rajendram, R., Schachter, R. J., Colasanto, M., et al. (2016) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-016-9170-9 · Cited by 77
Recent Advances in the Genetics of Autism Spectrum Disorder
Rubeis, S. D., & Buxbaum, J. D. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0553-1 · Cited by 89
Copy number variants in autism spectrum disorders
Vicari, S., Napoli, E., Cordeddu, V., Menghini, D., Alesi, V., Loddo, S., Novelli, A., & Tartaglia, M. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.02.012 · Cited by 83
Modeling the functional genomics of autism using human neurons
Konopka, G., Wexler, E., Rosen, E., Mukamel, Z., Osborn, G. E., Chen, L., Lu, D., Gao, F., Gao, K., Lowe, J. K., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.60 · Cited by 78
Self-citationPaired-Duplication Signatures Mark Cryptic Inversions and Other Complex Structural Variation
Brand, H., Collins, R. L., Hanscom, C., Rosenfeld, J. A., Pillalamarri, V., Stone, M. R., Kelley, F., Mason, T., Margolin, L., Eggert, S., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.05.012 · Cited by 79
Identification of a distinct developmental and behavioral profile in children with Dup15q syndrome
DiStefano, C., Gulsrud, A. C., Huberty, S., Kasari, C. L., Cook, E. H., Reiter, L. T., Thibert, R. L., & Jeste, S. (2016) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-016-9152-y · Cited by 85
“25–3 % depending on sample ascertainment [10–14].”
Chen, S., Fragoza, R., Klei, L., Liu, Y., Wang, J., Roeder, K., Devlin, B., & Yu, H. (2018) · Nature Genetics · doi:10.1038/s41588-018-0130-z · Cited by 74
Minor physical anomalies in autism: a meta-analysis
Özgen, M. H., Hop, J., Hox, J. J., Beemer, F. A., & van Engeland, H. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.75 · Cited by 82
Ziats, M. N., & Rennert, O. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024691 · Cited by 75
“identified many chromosomal hot spots in ASD [16,17].”
BackgroundPearson, N., Charman, T., Happé, F., Bolton, P. F., & McEwen, F. S. (2018) · Autism Research · doi:10.1002/aur.2035 · Cited by 75
“, 2007], and increased numbers of de novo genetic mutations in patients with sporadic autism [Sebat et al., 2007].”
BackgroundShooting a moving target. Researching autism genes: An interview study with professionals
Hens, K., Peeters, H., & Dierickx, K. (2015) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2015.12.009 · Cited by 77
Gurnett, C. A., Veile, R., Zempel, J., Blackburn, L., Lovett, M., & Bowcock, A. (2008) · Archives of Neurology · doi:10.1001/archneur.65.4.550 · Cited by 75
Zhao, J., & Grant, S. F. A. (2011) · Journal of Obesity · doi:10.1155/2011/845148 · Cited by 93
“However, they have led the way in the uncovering of CNVs in common disorders such as autism [107–110], attention-deficit hyperactivity disorder [111], and schizophrenia [112–114].”
BackgroundThe Broader Autism Phenotype in Simplex and Multiplex Families
Gerdts, J. A., Bernier, R., Dawson, G., & Estes, A. M. (2012) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-012-1706-6 · Cited by 78
DPP6 localization in brain supports function as a Kv4 channel associated protein
Clark, B., Kwon, E., Maffie, J., Jeong, H.-Y., Nadal, M., Strop, P., & Rudy, B. (2008) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.008.2008 · Cited by 83
Freitag, C. M., Agelopoulos, K., Huy, E., Rothermundt, M., Krakowitzky, P., Meyer, J., Deckert, J., von Gontard, A., & Hohoff, C. (2009) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-009-0043-6 · Cited by 84
“This seems to be relatively high, compared to the reported rate of 7–44% CNVs in a genome-wide analysis [16, 24], taking into account the expected differing CNV rates of locus- versus genome-wide studies.”
BackgroundResultPTEN: Local and Global Modulation of Neuronal Function in Health and Disease
Knafo, S., & Esteban, J. A. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2016.11.008 · Cited by 80
Neurons with Complex Karyotypes Are Rare in Aged Human Neocortex
Chronister, W. D., Burbulis, I. E., Wierman, M. B., Wolpert, M. J., Haakenson, M. F., Smith, A. C. B., Kleinman, J. E., Hyde, T. M., Weinberger, D. R., Bekiranov, S., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.107 · Cited by 74
A double hit implicates DIAPH3 as an autism risk gene
Vorstman, J. A. S., van Daalen, E., Jalali, G. R., Schmidt, E. R. E., Pasterkamp, R. J., de Jonge, M., Hennekam, E. A. M., Janson, E., Staal, W. G., van der Zwaag, B., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.26 · Cited by 74
“3 Recently, there has been a growing interest in the function of structural genomic rearrangements, including cytogenetic abnormalities and copy number variants (CNVs) associated with autism”
BackgroundAldinger, K. A., Kogan, J., Kimonis, V., Fernandez, B., Horn, D., Klopocki, E., Chung, B., Toutain, A., Weksberg, R., Millen, K. J., et al. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35700 · Cited by 72
“Numerous patients with terminal deletions of chromosome 22q13 have been reported [Phelan and Rogers, 1993; Wilson et al., 2003; Sebat et al., 2007; Szatmari et al., 2007; Marshall et al., 2008; Dhar et al., 2010; Bonaglia et al., 2011; Sarasua et al., 2011].”
BackgroundRNA-mediated epigenetic regulation of DNA copy number
Nowacki, M., Haye, J. E., Fang, W., Vijayan, V., & Landweber, L. F. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012236107 · Cited by 74
“D copy number profoundly influences evolution (1–4), permitting changes in gene and protein expression (5–7) that may be acted upon by positive selection (7), permit adaptation (8–11), or have links to human genetic disease (12) and disease susceptibility (13–15), including autism-spectrum disorders (16) and several c…”
BackgroundNagamani, S. C. S., Erez, A., Ben‐Zeev, B., Frydman, M., Winter, S. C., Zeller, R. S., El‐Khechen, D., Escobar, L., Stankiewicz, P., Patel, A., et al. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.157 · Cited by 80
McMullan, D. J., von Bonin, M., Hehir‐Kwa, J. Y., Vries, B. B. A. D., Dufke, A., Rattenberry, E., Steehouwer, M., Moruz, L., Pfundt, R., de Leeuw, N., et al. (2009) · Human Mutation · doi:10.1002/humu.21015 · Cited by 87
“Rare de novo copy number variations (CNVs) are a frequent cause of many common neurological disorders, including autism [Marshall et al., 2008; Sebat et al., 2007; The Autism Genome Project Consortium, 2007], schizophrenia [Stefansson et al., 2008; Walsh et al., 2008], and mental retardation (MR)…”
BackgroundEmerging phenotyping strategies will advance our understanding of psychiatric genetics
Sanchez‐Roige, S., & Palmer, A. A. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0609-7 · Cited by 77
A Likelihood-Based Framework for Variant Calling and De Novo Mutation Detection in Families
Li, B., Chen, W., Zhan, X., Busonero, F., Sanna, S., Sidore, C., Cucca, F., Kang, H. M., & Abecasis, G. R. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002944 · Cited by 78
“Although some de novo events, including copy number variants in particular have been extensively studied using microarrays [12,14,15], next generation sequencing will facilitate examination of other types of de novo events, including point mutations [13,16–20].”
BackgroundDe novo Mutations (DNMs) in Autism Spectrum Disorder (ASD): Pathway and Network Analysis
Alonso-González, A., Rodriguez‐Fontenla, C., & Carracedo, Á. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00406 · Cited by 87
The 7q11.23 Protein DNAJC30 Interacts with ATP Synthase and Links Mitochondria to Brain Development
Tebbenkamp, A. T. N., Varela, L., Choi, J., Paredes, M. I., Giani, A. M., Song, J. E., Šestan-Peša, M., Franjic, D., Sousa, A. M. M., Liu, Z.-W., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.014 · Cited by 76
Gene expression studies in autism: Moving from the genome to the transcriptome and beyond
Voineagu, I. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.07.017 · Cited by 72
“Two studies (Morrow et al., 2008; Sebat et al., 2007) have demonstrated that de novo CNVs occur more frequently among ASD cases than among controls.”
Autism Spectrum Disorder Genetics: Diverse Genes with Diverse Clinical Outcomes
Talkowski, M. E., Minikel, E. V., & Gusella, J. F. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000002 · Cited by 72
Optimal Sparse Segment Identification With Application in Copy Number Variation Analysis
Jeng, X. J., Cai, T., & Li, H. (2010) · Journal of the American Statistical Association · doi:10.1198/jasa.2010.tm10083 · Cited by 83
Miller, M. T., Mileni, M., Comoletti, D., Stevens, R. C., Harel, M., & Taylor, P. (2011) · Structure · doi:10.1016/j.str.2011.03.011 · Cited by 69
“Identified genetic abnormalities include copy number variations (Glessner et al., 2009; Rujescu et al., 2009; Sebat et al., 2007; Szatmari et al., 2007), chromosomal alterations (Kim et al.”
BackgroundInfluentialSt. Pourcain, B., Wang, K., Glessner, J. T., Golding, J., Steer, C., Ring, S. M., Skuse, D. H., Grant, S. F. A., Hakonarson, H., & Davey Smith, G. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09121789 · Cited by 68
“It has been shown that the genetic architecture of autism spectrum disorder is highly heterogeneous, often involving rare Mendelian and de novo mutations (6).”
BackgroundSelf-citationBen-David, E., Granot-Hershkovitz, E., Monderer-Rothkoff, G., Lerer, E., Levi, S., Yaari, M., Ebstein, R. P., Yirmiya, N., & Shifman, S. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr283 · Cited by 69
Yin, C., Chen, H.-I., Li, L., Chien, Y., Liao, H., Chou, M. C., Chou, W., Tsai, W., Chiu, Y., Wu, Y., et al. (2016) · Molecular Autism · doi:10.1186/s13229-016-0087-7 · Cited by 75
“rare de novo CNVs in ASD using array comparative genomic hybridization (aCGH) method [7] was supported by a large-scale CNV study implemented by the Autism Genome Project (AGP) showing that the difference was mainly contributed by the deletion-type CNVs [8].”
MethodNeuron-enriched RNA-binding Proteins Regulate Pancreatic Beta Cell Function and Survival
Juan‐Mateu, J., Rech, T. H., Villate, O., Lizárraga-Mollinedo, E., Wendt, A., Turatsinze, J., Brondani, L. D. A., Nardelli, T. R., Nogueira, T. C., Esguerra, J. L. S., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.748335 · Cited by 77
The impact of chromosomal microarray on clinical management: a retrospective analysis
Henderson, L. B., Applegate, C. D., Wohler, E., Sheridan, M. B., Hoover-Fong, J., & Batista, D. A. S. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.18 · Cited by 71
Genome-wide copy number variation analysis in a Chinese autism spectrum disorder cohort
Guo, H., Peng, Y., Hu, Z., Li, Y., Xun, G., Ou, J., Sun, L., Xiong, Z., Liu, Y., Wang, T., et al. (2017) · Scientific Reports · doi:10.1038/srep44155 · Cited by 71
Accuracy of CNV Detection from GWAS Data
Zhang, D., Qian, Y., Akula, N., Alliey‐Rodriguez, N., Tang, J., Study, T. B. G., Gershon, E. S., & Liu, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014511 · Cited by 81
“CNVs have recently attracted considerable interest as a source of genetic variation because they may play an important role in the etiology of complex diseases and in evolution [1–14].”
BackgroundThe landscape of copy number variations in F innish families with autism spectrum disorders
Kanduri, C., Kantojärvi, K., Salo, P., Vanhala, R., Buck, G., Blancher, C., Lähdesmäki, H. J., & Järvelä, I. E. (2015) · Autism Research · doi:10.1002/aur.1502 · Cited by 74
“…al. 2013; Girirajan, Johnson, et al. 2013; Griswold et al., 2012; Jacquemont et al., 2006; Levy et al., 2011; Marshall et al., 2008; O’Roak et al., 2011; Pinto et al., 2010; Prasad et al., 2012; Sanders et al., 2012; Sebat et al., 2007; Szatmari et al., 2007; Wang et al., 2009; Weiss et al., 2009).”
BackgroundResultMcDiarmid, T. A., Belmadani, M., Liang, J., Meili, F., Mathews, E., Mullen, G. P., Hendi, A., Wong, W.-R., Rand, J. B., Mizumoto, K., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912049116 · Cited by 78
Friedman, J. M., Adam, S., Arbour, L. T., Armstrong, L., Baross, Á., Birch, P. H., Boerkoel, C. F., Chan, S. Y., Chai, D., Delaney, A. D., et al. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-526 · Cited by 75
Glancy, M., Barnicoat, A. J., Vijeratnam, R., de Souza, S., Gilmore, J., Huang, S., Maloney, V. K., Thomas, N. S., Bunyan, D. J., Jackson, A., et al. (2008) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.133 · Cited by 75
Association of GTF2i in the Williams-Beuren Syndrome Critical Region with Autism Spectrum Disorders
Malenfant, P., Liu, X., Hudson, M. L., Qiao, Y., Hrynchak, M. A., Riendeau, N., Hildebrand, M. J., Cohen, I. L., Chudley, A. E., Forster‐Gibson, C., et al. (2011) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-011-1389-4 · Cited by 80
“Recent studies have reported different microdeletions (dels) and microduplications (dups) in 5–28% of individuals with ASDs, suggesting that such abnormalities might be a common etiological mechanism for this group of disorders (Jacquemont et al. 2006; Sebat et al. 2007; Vorstman et al. 2006).”
BackgroundThomas, M. S. C., Knowland, V. C. P., & Karmiloff-Smith, A. (2011) · Psychological Review · doi:10.1037/a0025234 · Cited by 70
Schizophrenia genetics: new insights from new approaches
Williams, H. J., Owen, M. J., & O’Donovan, M. C. (2009) · British Medical Bulletin · doi:10.1093/bmb/ldp017 · Cited by 86
Tordjman, S., Cohen, D., Anderson, G. M., Botbol, M., Canitano, R., Coulon, N., & Roubertoux, P. L. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.01.014 · Cited by 76
“SNPs and CNVs have both been reported to play a major role in autism incidence (Iossifov et al., 2012; Neale et al., 2012; O’Roak et al., 2012; Sanders et al., 2012; Sebat et al., 2007; Yu et al., 2012).”
BackgroundNguyen, R. L., Medvedeva, Y. V., Ayyagari, T., Schmunk, G., & Gargus, J. J. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.08.003 · Cited by 77
Wang, W., Corominas, R., & Lin, G. N. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00258 · Cited by 70
“It has been estimated that CNVs are responsible for a considerable percentage of the genetic causes in some psychiatric disorders such as ∼10% of simplex cases of ASD (Sebat et al., 2007).”
BackgroundGenetic and cognitive windows into circuit mechanisms of psychiatric disease
Arguello, P. A., & Gogos, J. A. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.11.007 · Cited by 75
Sousa, I., Clark, T. G., Holt, R., Pagnamenta, A. T., Mulder, E. J., Minderaa, R. B., Bailey, A. J., Battaglia, A., Klauck, S. M., Poustka, F., et al. (2010) · Molecular Autism · doi:10.1186/2040-2392-1-7 · Cited by 67
“Additionally, different markers within LRRTM3 were differently associated to multiplex and singleton families, supporting the theory that we are looking at genetically different groups within the same population that have different patterns of ASD traits [59,60].”
Association testing of copy number variants in schizophrenia and autism spectrum disorders
Crespi, B. J., & Crofts, H. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-15 · Cited by 76
“[22], Supplementary Table 2 in Szatmari et al.”
BackgroundSynaptic Signaling and Aberrant RNA Splicing in Autism Spectrum Disorders
Smith, R. M., & Sadée, W. (2011) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2011.00001 · Cited by 74
“Finally, the gene encoding RNA binding protein, FOX-1 homolog 1 (RBFOX1; also known as A2BP1 and FOX1) was found to be partially translocated and deleted in an autistic female patient (Martin et al., 2007; Sebat et al., 2007).”
Evidence for differential alternative splicing in blood of young boys with autism spectrum disorders
Stamova, B. S., Tian, Y., Nordahl, C. W., Shen, M. D., Rogers, S. J., Amaral, D. G., & Sharp, F. R. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-30 · Cited by 74
An open resource of structural variation for medical and population geneticsPreprint
Collins, R. L., Brand, H., Karczewski, K. J., Zhao, X., Alföldi, J., Francioli, L. C., Khera, A. V., Lowther, C., Gauthier, L. D., Wang, H., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/578674 · Cited by 77
International Molecular Genetic Study of Autism Consortium (IMGSAC), Sykes, N. H., Toma, C., Wilson, N., Volpi, E. V., Sousa, I., Pagnamenta, A. T., Tancredi, R., Battaglia, A., Maestrini, E., et al. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.47 · Cited by 69
“Recent reports have suggested that the prevalence of de novo CNVs in singleton families is between 7-10% whilst in multiplex families it is 2-3%11,13.”
The role of genetics and genomics in clinical psychiatry
Hoehe, M. R., & Morris-Rosendahl, D. J. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.3/mhoehe · Cited by 66
Whole Genome Scanning: Resolving Clinical Diagnosis and Management Amidst Complex Data
Ali‐Khan, S. E., Daar, A. S., Shuman, C. T., Ray, P. N., & Scherer, S. W. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e3181b0cbd8 · Cited by 72
Possible association between the androgen receptor gene and autism spectrum disorder
Henningsson, S., Jönsson, L., Ljunggren, E., Westberg, L., Gillberg, C. I., Råstam, M., Anckarsäter, H. S., Nygren, G., Landén, M., Thuresson, K., et al. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.12.007 · Cited by 73
Morphological Features in Children with Autism Spectrum Disorders: A Matched Case–Control Study
Özgen, M. H., Hellemann, G. S., Stellato, R. K., Lahuis, B., van Daalen, E., Staal, W., Rozendal, M., Hennekam, R. C. M., Beemer, F. A., & van Engeland, H. (2010) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1018-7 · Cited by 76
Gothelf, D., Frisch, A., Michaelovsky, E., Weizman, A., & Shprintzen, R. J. (2009) · Journal of Mental Health Research in Intellectual Disabilities · doi:10.1080/19315860902756136 · Cited by 84
“In conclusion, the recent innovative publications on the association of copy number variations (i.e. deletions/insertions) with genetic susceptibility to autism (Sebat et al., 2007) and schizophrenia (Xu et al., 2008) have rekindled the interest in VCFS.”
Small Deletion Variants Have Stable Breakpoints Commonly Associated with Alu Elements
de Smith, A. J., Walters, R. G., Coin, L. J. M., Steinfeld, I., Yakhini, Z., Sladek, R., Froguel, P., & Blakemore, A. I. F. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003104 · Cited by 65
“7% of heritable variation in gene expression [7], and have been associated with a number of diseases, such as autism [8], glomerulonephritis [9], and resistance to HIV [10].”
BackgroundBehavioral and Cerebellar Transmission Deficits in Mice Lacking the Autism-Linked Gene Islet Brain-2
Giza, J., Urbanski, M. J., Prestori, F., Bandyopadhyay, B., Yam, A., Friedrich, V., Kelley, K., D'Angelo, E., & Goldfarb, M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1161-10.2010 · Cited by 68
“3 among individuals with ASD and the related Phelan–McDermid syndrome have defined the SHANK3 gene, located 1 Mb from the chromosome terminus, as within the minimal deleted region (Wilson et al., 2003; Durand et al., 2007; Sebat et al., 2007; Delahaye et al., 2009).”
BackgroundInfluentialA Practical Guide for Structural Variation Detection in the Human Genome
Yang, L. (2020) · Current Protocols in Human Genetics · doi:10.1002/cphg.103 · Cited by 77
“Due to its high-throughput nature, microarray was widely used to study CNVs in normal populations (Conrad, Andrews, Carter, Hurles, & Pritchard, 2005; McCarroll et al., 2008), as well as in individuals with disease (Bochukova et al., 2010; Sebat et al., 2007; Zack et al., 2013).”
BackgroundBreckpot, J., Thienpont, B., Arens, Y. H. J. M., Tranchevent, L.-C., Vermeesch, J. R., Moreau, Y., Gewillig, M. H. M. L., & Devriendt, K. (2011) · Cytogenetic and Genome Research · doi:10.1159/000331272 · Cited by 68
“…holds true at higher resolution: several examples from literature have demon- strated that de novo CNVs found in patients are not necessarily causal [Itsara et al., 2010; Vermeesch et al., 2011], and imbalances 1 100 kb have shown to arise de novo in 1 1% of normal individuals [Sebat et al., 2007].”
BackgroundThe Genetics of Autism Spectrum Disorders – A Guide for Clinicians
Heil, K. M., & Schaaf, C. P. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0334-3 · Cited by 71
Raymond, L. J., Deth, R. C., & Ralston, N. V. C. (2014) · Autism Research and Treatment · doi:10.1155/2014/164938 · Cited by 81
“Observations from family studies suggest that ASD has a strong genetic component [103–105], although the failure to identify genetic factors affecting more than a small proportion of ASD cases suggests that multiple etiologies may be responsible for the pathologies and neurobehavioral features of the disorder [106–117…”
BackgroundVaccine-Related Beliefs and Practices of Parents of Children with Autism Spectrum Disorders
Bazzano, A., Zeldin, A. S., Schuster, E., Barrett, C., & Lehrer, D. (2012) · American Journal on Intellectual and Developmental Disabilities · doi:10.1352/1944-7558-117.3.233 · Cited by 69
“The specific genetic determinants, as well as their interaction with a variety of environmental factors, which are responsible for ASD are being actively researched (Buxbaum et al., 2001; Cook et al., 1997; Sebat et al., 2007).”
BackgroundNuclear and Mitochondrial Genome Defects in Autisms
Smith, M., Spence, M. A., & Flodman, P. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03571.x · Cited by 67
Structure and Function of SLC4 Family HCO3- Transporters
Liu, Y., Yang, J., & Chen, L.-M. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00355 · Cited by 64
“Dysfunctions of these transporters are associated with a broad spectrum of pathological conditions, including central nervous system diseases (such as mental retardation, migraine, epilepsy, autism, drug addiction) (Sander et al., 2002; Demirci et al., 2006; Sebat et al., 2007; Gurnett et al., 2008; Krepischi et al.,…”
BackgroundGenetic heterogeneity in autism: From single gene to a pathway perspective
An, J., & Claudianos, C. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.06.013 · Cited by 76
Matsunami, N., Hadley, D., Hensel, C. H., Christensen, G. B., Kim, C., Frackelton, E. C., Thomas, K., da Silva, R. P., Stevens, J., Baird, L. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052239 · Cited by 76
Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH
Bittel, D. C., Yu, S., Newkirk, H. L., Kibiryeva, N., Holt, A., Butler, M. G., & Cooley, L. D. (2009) · Cytogenetic and Genome Research · doi:10.1159/000207515 · Cited by 77
“In addition, recent studies of the human genome have found a greater than expected level of copy number variability which may contribute to genetic diversity and/or human disease (Barrett et al., 2004; Conrad et al., 2006; Fiegler et al., 2006; Khaja et al., 2006; Komura et al., 2006; Perry et al., 2006; Redon et al.,…”
BackgroundThe role of Pax6 in brain development and its impact on pathogenesis of autism spectrum disorder
Kikkawa, T., Casingal, C. R., Chun, S. H., Shinohara, H. M., Hiraoka, K., & Osumi, N. (2018) · Brain Research · doi:10.1016/j.brainres.2018.02.041 · Cited by 77
Metadata
- Authors
- Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., Leotta, A., Pai, D., Zhang, R., Lee, Y.-H., Hicks, J., Spence, S. J., Lee, A. T., Puura, K., Lehtimäki, T., Ledbetter, D., Gregersen, P. K., Bregman, J., Sutcliffe, J. S., Jobanputra, V., Chung, W., Warburton, D., King, M.-C., Skuse, D., Geschwind, D. H., Gilliam, T. C., Ye, K., & Wigler, M.
- Affiliations
- National Institutes of Health (US)
- Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA.
- Corresponding author
- Sebat, Jonathan
- Malhotra, Dheeraj
- Troge, Jennifer
- Wigler, Michael
- ORCID
- Venue
- Science
- Published
- 2007-04-20
- Volume
- 316
- Issue
- 5823
- Pages
- 445-449
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC2993504
- OpenAlex
- W1971321176
- Semantic Scholar
- 39990d887387b14f6d8e6918b37c6f8ea93bf8ff
- Cited by
- 2,795
- References
- 33
- Citations by year
- 2026: 34 · 2025: 58 · 2024: 55 · 2023: 70 · 2022: 90 · 2021: 126 · 2020: 129 · 2019: 109 · 2018: 105 · 2017: 114 · 2016: 130 · 2015: 183 · 2014: 168 · 2013: 217 · 2012: 226
- FWCI
- 132.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute of Mental Health (R01MH061009, MH076431, MH 61009, MH 64547, R01MH064547, R01MH076431)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- de novo copy number variation, autism spectrum disorder, germline mutations, genetic risk factors, chromosomal abnormalities, candidate genomic regions
- MeSH terms
- Autistic Disorder, Child, Female, Humans, Male, Markov Chains, Mutation, Nucleic Acid Hybridization, Parents, Genome, Human, Case-Control Studies, Gene Deletion, In Situ Hybridization, Fluorescence, Germ-Line Mutation, Gene Dosage, Microsatellite Repeats, Genetic Predisposition to Disease, Oligonucleotide Array Sequence Analysis, Gene Duplication, Cytogenetic Analysis, Asperger Syndrome, Siblings
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.